BOLCHINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 197
AS - Asia 172
EU - Europa 65
SA - Sud America 25
AF - Africa 4
Totale 463
Nazione #
US - Stati Uniti d'America 179
SG - Singapore 68
CN - Cina 38
BD - Bangladesh 24
BR - Brasile 23
IT - Italia 20
HK - Hong Kong 18
CA - Canada 13
VN - Vietnam 12
FR - Francia 7
TR - Turchia 7
PL - Polonia 6
RU - Federazione Russa 6
DE - Germania 5
GB - Regno Unito 4
NL - Olanda 4
FI - Finlandia 3
MX - Messico 3
DZ - Algeria 2
IE - Irlanda 2
IN - India 2
LT - Lituania 2
UA - Ucraina 2
AR - Argentina 1
CR - Costa Rica 1
ES - Italia 1
GM - Gambi 1
IQ - Iraq 1
JP - Giappone 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
VE - Venezuela 1
Totale 463
Città #
Singapore 47
Ashburn 29
San Jose 19
Hong Kong 18
The Dalles 16
Los Angeles 13
Beijing 12
Chicago 9
Ho Chi Minh City 7
Istanbul 6
Warsaw 6
Lauterbourg 5
Montreal 5
New York 5
Buffalo 4
Council Bluffs 4
Monza 4
Santa Clara 4
Denver 3
Houston 3
Milan 3
Munich 3
Orem 3
San Francisco 3
Seattle 3
Toronto 3
Amsterdam 2
Boston 2
Catania 2
Charlotte 2
Chennai 2
Dallas 2
Dublin 2
Haiphong 2
Ottawa 2
Phoenix 2
Portsmouth 2
Shijiazhuang 2
Turku 2
Verona 2
Americana 1
Annaba 1
Antalya 1
Araçatuba 1
Basra 1
Belo Horizonte 1
Belém 1
Bismarck 1
Bologna 1
Bratislava 1
Brooklyn 1
Butiá 1
Cap-Saint-Ignace 1
Caracas 1
Dalian 1
Dearborn 1
Dulles 1
Düsseldorf 1
Elk Grove Village 1
Feira de Santana 1
Floral Park 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Goiânia 1
Grand Rapids 1
Guarulhos 1
Hangzhou 1
Hanoi 1
Helsinki 1
Hermosillo 1
Honolulu 1
Igarapé 1
Itabira 1
Itabirito 1
Jackson 1
Joinville 1
João Pessoa 1
Kryvyi Rih 1
Laayoune 1
Lanús 1
London 1
Maracanaú 1
Mexico City 1
Miami 1
Nam Định Province 1
Newark 1
Ninh Bình 1
Oryol 1
Pederneiras 1
Pedro Leopoldo 1
Pirapora 1
Pittsburgh 1
Ponta Porã 1
Porto Alegre 1
Poá 1
Redondo Beach 1
Riga 1
Rome 1
San José 1
Totale 325
Nome #
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 100
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 97
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 89
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 66
Photophobia and migraine outcome during treatment with galcanezumab 60
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 57
Totale 469
Categoria #
all - tutte 1.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025138 0 0 0 30 13 12 13 7 11 13 23 16
2025/2026331 27 34 14 49 40 21 60 5 22 23 20 16
Totale 469